Cormorant Asset Management
Venture capital
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
20Deep-tech portfolio11 active
9Portfolio exitsAcquired or listed
2Raises, 12 monthsLatest: Quince Therapeutics
56Co-investorsShare a portfolio company
Portfolio · 20 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Nexo Therapeutics | Biotech | Active | Mar 27, 2026 | $30.0M |
| Supira Medical | Medtech | Active | Apr 3, 2025 | $220.7M |
| 858 Therapeutics | Biotech | Active | Jul 11, 2024 | $65.2M |
| Expansion Therapeutics | Biotech | Active | Oct 12, 2021 | $73.6M |
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| Aspen Neuroscience | Biotech | Active | — | — |
| GC Therapeutics | Biotech | Active | — | — |
| GondolaBio | Biotech | Active | — | — |
| Orbis Medicines | Biotech | Active | — | — |
| Parabilis Medicines | Biotech | Active | — | — |
| Triveni Bio | Biotech | Active | — | — |
| Quince Therapeutics | Biotech | Public | Jun 11, 2026 | $226.2M |
| Neurona Therapeutics | Biotech | Acquired | Apr 4, 2025 | $282.8M |
| Interius BioTherapeutics | Biotech | Acquired | Jun 3, 2024 | $118.1M |
| Solid Biosciences | Biotech | Public | Dec 9, 2022 | $109.2M |
| Revolution Medicines | Biotech | Public | Nov 15, 2019 | $204.2M |
| Cabaletta Bio | Biotech | Public | Jan 14, 2019 | $88.3M |
| Attovia Therapeutics | Biotech | Public | — | — |
| Day One Biopharmaceuticals | Biotech | Acquired | — | — |
| Praxis Precision Medicine | Biotech | Public | — | — |
Peer ranks
Portfolio size#16
Portfolio exits#13
Raises, 12 months#12
Co-investors#23
Co-investors
- Frazier Healthcare PartnersVenture capital4 shared
- ARCH VentureVenture capital3 shared
- Foresite CapitalVenture capital3 shared
- RA CapitalVenture capital3 shared
- Redmile GroupVenture capital3 shared
- Versant VenturesVenture capital3 shared
- Atlas VentureVenture capital2 shared
- Bain Capital Life SciencesVenture capital2 shared
- Boxer CapitalVenture capital2 shared
- Brookside CapitalVenture capital2 shared
Sectors
- Biotech19
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.